Free Trial

Janux Therapeutics (JANX) Earnings Date, Estimates & Call Transcripts

Janux Therapeutics logo
$25.67 +0.13 (+0.52%)
As of 10:07 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Janux Therapeutics Earnings Summary

Latest Q4
Earnings Date
Feb. 27Estimated
Consensus EPS
(Feb. 27)
-$0.49
Actual EPS
(Feb. 27)
-$0.36 Beat By $0.13

Janux Therapeutics released Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.36, which beat analysts' consensus estimates of -$0.49 by $0.13. With a trailing EPS of -$1.28, Janux Therapeutics' earnings are expected to decrease next year, from ($1.38) to ($2.35) per share.

Q4 2024 Earnings Resources

Get Janux Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Janux Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

JANX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JANX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Janux Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.48-$0.35-$0.43
Q2 20253-$0.52-$0.36-$0.45
Q3 20253-$0.58-$0.36-$0.47
Q4 20253-$0.59-$0.37-$0.47

Janux Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/27/2025Q4 2024-$0.49-$0.36+$0.13-$0.36--
11/6/2024Q3 2024-$0.33-$0.51 -$0.18-$0.51$1.50M$0.44M
8/7/2024Q2 2024-$0.31-$0.11+$0.20-$0.11$0.77M$8.90M
5/7/2024Q1 2024-$0.35-$0.30+$0.05-$0.30$0.98M$1.25M
3/8/2024Q4 2023-$0.37-$0.25+$0.12-$0.25$0.98M$2.46M
11/7/2023Q3 2023-$0.46-$0.25+$0.21-$0.25$1.22M$2.52M
8/8/2023Q2 2023-$0.52-$0.42+$0.10-$0.42$1.25M$1.06M
5/9/2023Q1 2023-$0.49-$0.42+$0.07-$0.42$1.69M$2.05M

Janux Therapeutics Earnings - Frequently Asked Questions

Janux Therapeutics (NASDAQ:JANX) last announced its quarterly earning data on Thursday, February 27, 2025. Learn more on JANX's earnings history.

In the previous quarter, Janux Therapeutics (NASDAQ:JANX) reported ($0.36) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.13. Learn more on analysts' earnings estimate vs. JANX's actual earnings.

Janux Therapeutics (NASDAQ:JANX) has a recorded annual revenue of $10.59 million.

Janux Therapeutics (NASDAQ:JANX) has a recorded net income of -$58.29 million. JANX has generated -$1.28 earnings per share over the last four quarters.

Janux Therapeutics's earnings are expected to decrease from ($1.38) per share to ($2.35) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:JANX) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners